Abstract
Horizontal pleiotropy can significantly confound causal estimates in Mendelian randomization (MR) studies, particularly when numerous instrumental variables (IVs) are employed. In this study we propose a novel statistical method, Mendelian Randomization analysis based on Z-scores (MRZ), to conduct robust and accurate MR analysis in the presence of pleiotropy. MRZ models the IV-outcome association z-score as a mixture distribution, separating the causal effect of the exposure on the outcome from pleiotropic effects specific to each IV. By classifying IVs into distinct categories (valid, uncorrelated pleiotropic, and correlated pleiotropic), MRZ constructs a likelihood function to estimate both causal and pleiotropic effects. Simulation studies demonstrate MRZ’s robustness, power, and accuracy in identifying causal effects under diverse pleiotropic scenarios and overlapped samples. In a bidirectional MR analysis of appendicular lean mass (ALM) and four lipid traits using both the UK Biobank (UKB)-internal datasets and the UKB-Global Lipids Genetics Consortium (GLGC) joint datasets, MRZ consistently identified a causal effect of ALM on total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C). Conversely, existing methods often detected mutual causal relationship between lipid traits and ALM, highlighting their susceptibility to confounding by horizontal pleiotropy. A randomized controlled experiment conducted in mice validated the absence of causal effect of TC on ALM, corroborating the MRZ findings and further emphasizing its resilience against pleiotropic biases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was partially supported by the funding from National Natural Science Foundation of China (32170670 to YFP, 81902181 to JJN), the Project of MOE Key Laboratory of Geriatric Diseases and Immunology (JYN202401 to HGR), and Suzhou Basic Research Program (Medical Application Basic Research) (SKY2023147 to JJN).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study (project number 41542) was covered by general ethical approval for the UKB study, and was approved by the Northwest Centre for Research Ethics Committee (11/NW/0382). All participants provided informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Access to UK Biobank data can be obtained by application to UK Biobank (https://www.ukbiobank.ac.uk/).
